These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1718376)

  • 1. The role of colony stimulating factors in cancer therapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1991; 12():307-26. PubMed ID: 1718376
    [No Abstract]   [Full Text] [Related]  

  • 2. Colony-stimulating factors in cancer therapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1992; 13():308-26. PubMed ID: 1382528
    [No Abstract]   [Full Text] [Related]  

  • 3. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 4. The myeloid colony-stimulating factors: introduction and overview.
    Peters WP
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):1-5. PubMed ID: 1712123
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
    Willemse PH; Boonstra H; de Vries EG
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
    [No Abstract]   [Full Text] [Related]  

  • 6. Colony-stimulating factors.
    Gordon MS; Gabrilove JL
    Curr Opin Oncol; 1990 Dec; 2(6):1152-8. PubMed ID: 1712236
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colony-stimulating factors].
    Uhl D
    Med Monatsschr Pharm; 1990 Jun; 13(6):162-4. PubMed ID: 1695708
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of CSF to cancer treatment].
    Takaku F
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
    Fan D; O'Brian CA; Ioannides CG; Clyne RK
    In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 13. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
    Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
    [No Abstract]   [Full Text] [Related]  

  • 14. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of GM-CSF in autologous bone marrow transplantation.
    Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
    Yamashita J; Kawamura T; Shoin K
    No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.